Tracking made easier
Once your goal is clear, you can decide between stimulant and non-stimulant approaches: Stimulant-based stacks deliver faster, more noticeable effects but require careful timing and periodic cycling (typically one to two weeks off every six to eight weeks) to prevent tolerance and maintain efficacy
FDA Approval Both tirzepatide and semaglutide are FDA-approved for blood sugar control in individuals with type 2 diabetes
Perovic, D., et al
By promoting a feeling of fullness, these injections help control cravings and reduce the urge to overeat, making it easier to stick to a balanced diet and avoid excess snacking
In addition, GLP-1RAs, reduce pancreatic islet -cell apoptosis, stimulate the proliferation and differentiation of -cells, and decrease body weight by suppressing food intake in patients with T2DM [8, 41,42,43]